PPG Directors Announce Quarterly Dividend of 45 Cents Per Share
Get Alerts PPG Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.6%
Revenue Growth %: +3.8%
Join SI Premium – FREE
PITTSBURGH--(BUSINESS WIRE)-- The board of directors of PPG (NYSE: PPG) today declared a regular quarterly dividend of 45 cents per share, payable June 12 to shareholders of record May 10.
This marks the company’s 479th consecutive dividend payment. PPG has raised its annual dividend payout for 46 consecutive years, and the company last raised its per share dividend in July 2017. PPG has paid uninterrupted annual dividends since 1899.
PPG: WE PROTECT AND BEAUTIFY THE WORLD™
At PPG (NYSE: PPG), we work every day to develop and deliver the paints, coatings and materials that our customers have trusted for more than 130 years. Through dedication and creativity, we solve our customers’ biggest challenges, collaborating closely to find the right path forward. With headquarters in Pittsburgh, we operate and innovate in more than 70 countries and reported net sales of $14.8 billion in 2017. We serve customers in construction, consumer products, industrial and transportation markets and aftermarkets. To learn more, visit www.ppg.com.
We protect and beautify the world is a trademark and the PPG Logo is a registered trademark of PPG Industries Ohio, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180419005872/en/
PPG
Media Contact:
Mark Silvey, +1-412-434-3046
Corporate
Communications
[email protected]
or
Investor
Contact:
John Bruno, +1-412-434-3466
Investor Relations
[email protected]
investor.ppg.com
Source: PPG
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PlanGap's 2026 Social Security Confidence Survey Finds 7 in 10 Americans 45+ Lack Confidence Benefits Will Remain Intact
- Statt Launches Advisory Board of Government Relations, Public Affairs, and Technology Leaders to Shape the Future of AI-Powered Public Policy Work
- SystImmune Announces First Approval of Iza-bren for the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma in China
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share